Post-Diagnostic Aspirin Use in Breast Cancer Treatment: A Systematic Review and Meta-Analysis of Survival Outcomes with Trial Sequential Analysis Validation
<b>Background</b>: Breast cancer is a leading cause of cancer-related mortality in women. Aspirin, an affordable anti-inflammatory drug, may have anticancer effects, but its impact on survival outcomes after breast cancer diagnosis remains unclear. This meta-analysis evaluates the role o...
Main Authors: | Po-Huang Chen, Tung-Lung Yang, Hong-Jie Jhou, Hsu-Lin Lee, Ming-Shen Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/15/1/44 |
Similar Items
-
Aspirin and risk of multiple myeloma in adults: A systematic review and meta-analysis
by: Shing Fung Lee, et al.
Published: (2017-01-01) -
The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis
by: Shuai Wang, et al.
Published: (2023-07-01) -
Efficacy and safety of aspirin as an adjunctive therapy in tubercular meningitis: A systematic review and meta-analysis
by: R. Rohilla, et al.
Published: (2021-04-01) -
What Does the Meta-Analysis Tell Us about Aspirin and COVID Survival?: Aspirin and COVID-19 Mortality.
by: Hesam Aldin Varpaei
Published: (2022-06-01) -
Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies
by: Yan Qiao, et al.
Published: (2018-03-01)